Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert) -- Ignore unavailable to you. Want to Upgrade?

To: Captain Jack who wrote (733)	5/13/1999 7:13:00 AM
From: John Carragher	Read Replies (1) \| Respond to of 942

cnbc mentioned yesterday there was an upgrade and wla has an analyst conference next week. They mentioned some new announcements. I sold my remaining stock yesterday @a loss to buy more net stocks. good luck John

To: Captain Jack who wrote (733)	5/13/1999 9:29:00 AM
From: margie	Respond to of 942

Hopefully WLA will return to its old trading range and higher, pre-Rezulin-FDA hearings and pre-WLA-AGPH merger. WLA traded between 70-85 between 7/98 to 1/99. The 10 day period to determine how the number of wla shares that Agouron shareholders will receive is over. Agouron shareholders will receive .894354 shares of wla, or 89.4354 shares of wla for each 100 shares of agph. Thanks for your work, Bill. The special meeting to vote on the merger between Warner-Lambert and Agouron is scheduled for May 17th. I also heard CNBC announce yesterday that Warner-lambert has an anlayst meeting next week, and to expect a very positve meeting. Both companies must be in a quiet period now. Apparently the arbs shorted WLA and were long agph. The April short interest for wla was very high - over 6.2 million shares short; an increase of 27.5% from March 1999, and those numbers were even higher than before the FDA-Rezulin meeting. WLA's increased short interest for April was not drug sector specific either. April's short interest for Pfizer and Merck decreased by 16.5% and 6.4% yet those stocks lost more $ than wla. The late day sell off is typical of a high short interest, although it can go either way, dependingâ€¦. Looks like this is one time the shorts were wrong with Agouron. April's short interest in Agouron was "only" +608,000, an improvement over the obscene short interest of over 6.6 MILLION shares short in November '98 and over 6.3 MILLION shares short in December 1998, in a company that only has about 31-33 million shares. Too bad the shorts never had to suffer, those a@#%#!** Good luck Agouron and Warner-Lambert. I'll miss Agouron, although they will still be there, as a subsidiary of WLA, after the vote on 5/17. Go imnr and Remune!